Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
2015 · BMC Cardiovascular Disorders · 71 citations
https://doi.org/10.1186/s12872-015-0137-7
M
Miguel Camafort
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
234
Papers
2.6K
Citations
24
h-index
66
i10-index
Miguel Camafort is an academic researcher from Instituto de Salud Carlos III. The author has contributed to research in topics: Blood Pressure and Hypertension Studies & Heart Failure Treatment and Management & Cardiac Health and Mental Health. The author has an h-index of 24, co-authored 199 publications.
ORCID: 0000-0002-8669-6410Papers by this author
worksDocumento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial
2018 · Hipertensión y Riesgo Vascular · 45 citations
https://doi.org/10.1016/j.hipert.2018.04.001
Targeting body composition in an older population: do changes in movement behaviours matter? Longitudinal analyses in the PREDIMED-Plus trial
2021 · BMC Medicine · 26 citations
https://doi.org/10.1186/s12916-020-01847-9
Diagnosis and management of resistant hypertension
2023 · Heart · 13 citations
https://doi.org/10.1136/heartjnl-2022-321730
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
2022 · Scientific Reports · 12 citations
https://doi.org/10.1038/s41598-022-08882-x
Adaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica
2017 · Gaceta Sanitaria · 11 citations
https://doi.org/10.1016/j.gaceta.2016.12.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat